Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Natural Language Processing | 8 | 2021 | 58 | 1.470 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 4 | 2021 | 142 | 1.370 |
Why?
|
| Pharmacovigilance | 3 | 2021 | 15 | 1.340 |
Why?
|
| Electronic Health Records | 6 | 2026 | 398 | 1.290 |
Why?
|
| Machine Learning | 7 | 2025 | 196 | 1.070 |
Why?
|
| Artificial Intelligence | 6 | 2025 | 216 | 0.940 |
Why?
|
| Computed Tomography Angiography | 1 | 2026 | 143 | 0.870 |
Why?
|
| Pulmonary Embolism | 1 | 2026 | 198 | 0.790 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 2 | 2021 | 48 | 0.730 |
Why?
|
| Data Mining | 4 | 2021 | 38 | 0.660 |
Why?
|
| Drug Therapy | 1 | 2019 | 56 | 0.590 |
Why?
|
| Radiology | 1 | 2021 | 263 | 0.510 |
Why?
|
| Information Storage and Retrieval | 4 | 2011 | 60 | 0.450 |
Why?
|
| Computer Graphics | 1 | 2014 | 19 | 0.410 |
Why?
|
| Publications | 1 | 2014 | 29 | 0.410 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2021 | 76 | 0.360 |
Why?
|
| Speech Recognition Software | 1 | 2011 | 1 | 0.350 |
Why?
|
| Algorithms | 6 | 2026 | 1052 | 0.340 |
Why?
|
| Community Participation | 1 | 2011 | 48 | 0.340 |
Why?
|
| Text Messaging | 1 | 2012 | 98 | 0.340 |
Why?
|
| Biomedical Research | 1 | 2014 | 263 | 0.330 |
Why?
|
| Software | 3 | 2025 | 401 | 0.310 |
Why?
|
| Point-of-Care Systems | 1 | 2011 | 137 | 0.300 |
Why?
|
| Telemedicine | 2 | 2020 | 376 | 0.280 |
Why?
|
| Humans | 24 | 2026 | 65650 | 0.280 |
Why?
|
| Delivery of Health Care | 1 | 2011 | 439 | 0.260 |
Why?
|
| Computational Biology | 2 | 2025 | 368 | 0.250 |
Why?
|
| Databases, Factual | 4 | 2023 | 888 | 0.250 |
Why?
|
| Lymphoma, Follicular | 1 | 2026 | 18 | 0.240 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2026 | 54 | 0.230 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2026 | 67 | 0.230 |
Why?
|
| Biostatistics | 1 | 2025 | 5 | 0.220 |
Why?
|
| HIV Infections | 2 | 2022 | 958 | 0.220 |
Why?
|
| Colon | 1 | 2025 | 148 | 0.210 |
Why?
|
| Surgical Wound Infection | 1 | 2025 | 126 | 0.210 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2026 | 377 | 0.200 |
Why?
|
| Research Personnel | 1 | 2023 | 82 | 0.180 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2022 | 129 | 0.180 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2022 | 95 | 0.170 |
Why?
|
| Hypoglycemia | 1 | 2022 | 64 | 0.170 |
Why?
|
| RNA | 1 | 2025 | 427 | 0.170 |
Why?
|
| Biomarkers, Tumor | 1 | 2025 | 526 | 0.170 |
Why?
|
| Semantics | 2 | 2011 | 58 | 0.170 |
Why?
|
| Causality | 1 | 2021 | 60 | 0.160 |
Why?
|
| Bibliometrics | 1 | 2020 | 35 | 0.160 |
Why?
|
| Language | 1 | 2021 | 155 | 0.150 |
Why?
|
| Support Vector Machine | 1 | 2019 | 25 | 0.150 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2019 | 26 | 0.150 |
Why?
|
| Radiography | 1 | 2021 | 558 | 0.150 |
Why?
|
| Adolescent Behavior | 1 | 2021 | 195 | 0.150 |
Why?
|
| Area Under Curve | 1 | 2019 | 149 | 0.150 |
Why?
|
| Narration | 1 | 2019 | 54 | 0.140 |
Why?
|
| Pattern Recognition, Automated | 1 | 2019 | 52 | 0.140 |
Why?
|
| Mobile Applications | 1 | 2020 | 142 | 0.140 |
Why?
|
| Smoking Cessation | 1 | 2023 | 553 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2022 | 630 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 733 | 0.110 |
Why?
|
| Probability | 1 | 2014 | 170 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2014 | 309 | 0.090 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2011 | 13 | 0.090 |
Why?
|
| Unified Medical Language System | 1 | 2011 | 6 | 0.090 |
Why?
|
| Software Design | 1 | 2011 | 28 | 0.090 |
Why?
|
| Online Systems | 1 | 2011 | 20 | 0.080 |
Why?
|
| Neoplasms | 1 | 2021 | 1376 | 0.080 |
Why?
|
| Automation | 1 | 2010 | 55 | 0.080 |
Why?
|
| Information Dissemination | 1 | 2011 | 114 | 0.080 |
Why?
|
| User-Computer Interface | 1 | 2010 | 127 | 0.080 |
Why?
|
| Databases, Genetic | 1 | 2010 | 91 | 0.080 |
Why?
|
| Registries | 2 | 2026 | 934 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2012 | 1026 | 0.070 |
Why?
|
| Internet | 1 | 2011 | 472 | 0.070 |
Why?
|
| Adolescent | 3 | 2022 | 6350 | 0.060 |
Why?
|
| Proteins | 1 | 2011 | 764 | 0.060 |
Why?
|
| Aged | 3 | 2026 | 15089 | 0.050 |
Why?
|
| Male | 4 | 2026 | 31295 | 0.050 |
Why?
|
| Middle Aged | 3 | 2026 | 18439 | 0.050 |
Why?
|
| Safe Sex | 1 | 2022 | 25 | 0.050 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2022 | 62 | 0.040 |
Why?
|
| Smokers | 1 | 2023 | 117 | 0.040 |
Why?
|
| Female | 4 | 2026 | 34309 | 0.040 |
Why?
|
| Risk Factors | 2 | 2021 | 5466 | 0.040 |
Why?
|
| Protein Interaction Mapping | 2 | 2011 | 69 | 0.040 |
Why?
|
| Cause of Death | 1 | 2021 | 221 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2022 | 502 | 0.040 |
Why?
|
| Biomarkers | 1 | 2025 | 1487 | 0.040 |
Why?
|
| Medication Systems | 1 | 2019 | 17 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1144 | 0.030 |
Why?
|
| Smoking | 1 | 2023 | 863 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 691 | 0.030 |
Why?
|
| Logistic Models | 1 | 2021 | 1273 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 1791 | 0.030 |
Why?
|
| Physicians | 1 | 2021 | 486 | 0.030 |
Why?
|
| Adult | 2 | 2023 | 17511 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2113 | 0.030 |
Why?
|
| Time Factors | 1 | 2021 | 3777 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2025 | 6948 | 0.020 |
Why?
|
| Expert Systems | 1 | 2011 | 4 | 0.020 |
Why?
|
| Clinical Medicine | 1 | 2011 | 16 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 4855 | 0.020 |
Why?
|
| Wisconsin | 1 | 2010 | 17 | 0.020 |
Why?
|
| Proteomics | 1 | 2011 | 299 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2010 | 274 | 0.020 |
Why?
|
| United States | 1 | 2021 | 8166 | 0.020 |
Why?
|